Helicos BioSciences rises on magazine feature
Shares of Helicos BioSciences Corp. (Nasdaq:HLCS) are higher on news before the opening that its technology will be mentioned in a report by Science Magazine. The April 4 issue of the weekly journal will describe how the Cambridge, Mass.-based company’s proprietary technology can re-sequence a viral genome.
At 3:55 p.m. ET, the stock had added $0.40, or 5%, to $8.51. For detailed price information and recent news stories about Helicos BioSciences, click HLCS.
